Linked Life Data

18752949

Source:http://linkedlifedata.com/resource/pubmed/id/18752949

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
18
pubmed:dateCreated
2008-9-15
pubmed:abstractText
The design, synthesis, and structure-activity studies of a novel series of BK B(1) receptor antagonists based on a 1-benzylbenzimidazole chemotype are described. A number of compounds, for example, 38g, with excellent affinity for the cynomolgus macaque and rat bradykinin B(1) receptor were discovered.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1464-3405
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5027-31
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
1-Benzylbenzimidazoles: the discovery of a novel series of bradykinin B(1) receptor antagonists.
pubmed:affiliation
Neurogen Corporation, 35 NE Industrial Road, Branford, CT 06405, USA.
pubmed:publicationType
Journal Article